# Metformin Versus Standard of Care Treatment in Pregnant Women With Prediabetes

> **NCT04523363** · PHASE4 · WITHDRAWN · sponsor: **Gianna Wilkie**

## Conditions studied

- Prediabetes; Complicating Pregnancy

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT04523363
- **Lead sponsor:** Gianna Wilkie
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-06-01
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was not funded and could not be performed
- **Last updated:** 2025-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04523363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04523363, "Metformin Versus Standard of Care Treatment in Pregnant Women With Prediabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04523363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*